share_log

Legend Biotech | 6-K: Legend Biotech Announced Results for the First Time from the Phase 2 CARTITUDE-2 Cohort D Study in Multiple Myeloma Patients

SEC ·  Jun 3 16:09
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more